Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SELB | Stock Option (Right to Buy) | Disposed to Issuer | -20K | -100% | 0 | Nov 13, 2023 | Common Stock | 20K | $2.10 | Direct | F1 | ||
transaction | SELB | Stock Option (Right to Buy) | Disposed to Issuer | -20K | -100% | 0 | Nov 13, 2023 | Common Stock | 20K | $3.00 | Direct | F2 | ||
transaction | SELB | Stock Option (Right to Buy) | Disposed to Issuer | -40K | -100% | 0 | Nov 13, 2023 | Common Stock | 40K | $4.01 | Direct | F3 | ||
transaction | SELB | Stock Option (Right to Buy) | Disposed to Issuer | -40K | -100% | 0 | Nov 13, 2023 | Common Stock | 40K | $3.31 | Direct | F4 | ||
transaction | SELB | Stock Option (Right to Buy) | Disposed to Issuer | -$81.4K | -87.5K | -100% | $0.93 | 0 | Nov 13, 2023 | Common Stock | 87.5K | $1.13 | Direct | F5 |
Id | Content |
---|---|
F1 | This option, which provided for vesting in thirty-six (36) substantially equal monthly installments over three years following the date of grant on June 14, 2019, was canceled in the merger (the "Merger") between Selecta Biosciences, Inc. and Cartesian Therapeutics, Inc. |
F2 | This option, which provided for vesting in full on June 17, 2021, was canceled in the Merger. |
F3 | This option, which provided for vesting in full on March 30, 2022, was canceled in the Merger. |
F4 | This option, which provided for vesting in full on January 3, 2023, was canceled in the Merger. |
F5 | This option, which provided for vesting in full on January 2, 2024, was canceled in the Merger in exchange for a cash payment of $81,375, representing the difference between the exercise price of the option and $2.06, the Cash-out Amount as applied in the Merger. |